
Jason Dykstra, PharmD, the owner of Chino Valley Pharmacy, shares his tips for getting through the pandemic.

Jason Dykstra, PharmD, the owner of Chino Valley Pharmacy, shares his tips for getting through the pandemic.

Medical science liaisons are biomedical professionals who are responsible for scientific management of multiple aspects of a product, such as a drug, diagnostic test, or medical device, before and after launch.

COVID-19 has spread to 180 countries and territories and includes and caused more than 44,000 so far, but this is not the first time a pandemic has occurred.

The CDC says hand washing is one of the most effective ways to reduce the spread of infectious diseases.

Some pharmacists and other health care experts are worried that patients, especially those with underlying conditions, may stop adhering to their medication regimens.

The American Society of Health-System Pharmacists has launched a new, free service to connect health care facilities with pharmacy personnel who can help alleviate potential staffing shortages.

“What she did for me this week is what defines heroic.”

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

New data from the FAIR Health white paper show that from 2017 to 2018, telehealth use grew 12% and use of retail clinics grew 10%.

New research in 5 human cancer cell lines revealed interdependencies between a tumor and its host’s microenvironment.

One of the results from the survey showed that 42% of American people do not wash their hands every time they use the restroom.

In addition, RUCDR has submitted an emergency use authorization request for a saliva collection method that will allow for broader population screening.

What was the initial reason that Detroit pharmacist James Vernor created the ginger ale, Vernors?

Camber Pharmaceuticals has announced that it has added Glycerin Liquid and 3 syrups to their increasingly diverse portfolio: Simple Syrup, Cherry Syrup and SoSweet® Syrup.

The state attorney general’s office and its State Board of Medical Examiners are limiting pharmacists and physicians from allowing patients to use certain medications for COVID-19.

The FDA has approved coagulation factor VIIA (recombinant)-jncw (Sevenfact, LFB) for the treatment and control of bleeding episodes occurring in adolescents aged 12 years and older with hemophilia A or B with inhibitors.

The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.

The USP has developed an online toolkit using guidelines from major public health organizations.

Today we’re celebrating the work of Mayank Amin, PharmD, RPh, MBA, owner of Skippack Pharmacy.

Pharmacists push against state-level limits on dispensing of hydroxychloroquine for coronavirus disease 2019.

Hospitals can apply at no cost to locate and trade critical supplies to help ease drug shortages during the pandemic.

PBMI informs, advises, and influences the industry on drug cost management.

One of the critical barriers surrounding the coronavirus disease 2019 (COVID-19) pandemic is the lack of access to testing, specifically among high-risk populations.

More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what physicians typically recommend for chronic pain relief via data from clinical studies, according to research published in PLOS ONE.

According to a recent study in the Heart journal, regular tub bathing is linked to a lower risk of death from heart disease and stroke.

Novartis and Rising Pharmaceuticals are donating doses of hydroxychloroquine to be utilized by researchers investigating safety and efficacy against COVID-19.

RedHill Biopharma Ltd today announced that it has completed the recently announced acquisition of the global rights to Movantik (naloxegol) for the treatment of opioid-induced constipation (OIC) from AstraZeneca.

Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.

The Department of Health and Human Services said that there are only 5 locations out of 67,000 pharmacy sites with the capacity to test for COVID-19 through the Community-Based Testing Site program.